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ABSTRACT: 
Walking tests, such as Incremental Shuttle (ISWT) and Six Minute (6MWT) Walk 
Tests, are recommended in the assessment of ambulatory oxygen for patients with 
Chronic Obstructive Pulmonary Disease (COPD). However, there is no evidence that 
these tests can be used interchangeably.  
Objectives: To compare ISWT and 6MWT in COPD patients with respect to 
indication for ambulatory oxygen therapy.  Design: Cross over design. Setting: 
Patients attended as out-patients. Participants:  50 patients with stable COPD (31 
male; age 67(43 - 83) yrs; mean (SD) FEV1 1.24 (0.62) l and 48.6(23.4) % predicted). 
Intervention:  Patients performed both ISWT and 6MWT whilst breathing air. 
Breathlessness (Borg Scale), percutaneous arterial oxygen saturation (SpO2) and 
heart rate were measured before and after both tests. Main outcome measures: 
Post test SpO2 and change from baseline. Results:  The mean change in saturation 
(SD) was -4.6 (6.2) % and -2.8 (5.3) % after the ISW and 6WM tests respectively. 
Using Bland and Altman plots the limits of agreement for difference in change in 
SpO2 (%) between the two tests were wide (-8.1 to 11.6) and clinically relevant. 
Sixteen patients (32%) met the criteria for ambulatory oxygen with ISWT and 13 
(26%) with 6MWT (p=0.32). 
Conclusions: In this study there was a wide variation between differences in 
exercise oxygen desaturation after ISWT compared with 6MWT supporting the 
premise that these tests should not be used interchangeably in the assessment of 
ambulatory oxygen for COPD patients.    
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INTRODUCTION: 
 
Chronic Obstructive Pulmonary Disease (COPD) is a disease characterised by 
airflow obstruction, which is usually progressive and non-reversible. Increasing 
severity of airflow obstruction, alveolar wall destruction and impairment in diffusing 
capacity leads to arterial hypoxaemia. Initially, hypoxaemia is experienced during 
physical activities (1) which may, in the advanced disease stage, progress into 
chronic type two respiratory failure. For these patients the provision of long-term 
oxygen therapy is a vital component of management (2-4). However, COPD is a 
heterogeneous disease, in many patients desaturation and arterial hypoxaemia 
occurs only on exercise. The provision of oxygen during exercise and activities of 
daily living, known as an ambulatory oxygen therapy may be beneficial for these 
patients. Ambulatory oxygen is recommended in order to allow the patient to spend 
longer periods outside the home, to increase daily activities (5;6) and to improve 
health related quality of life (7). However, in order to maximise effectiveness, titration 
and usage of oxygen, accurate and appropriate assessment of ambulatory oxygen is 
required.  
 
Currently, according to British Thoracic Society guidelines (6), when oxygen 
desaturation of 4% to a value < 90% is demonstrated after either a maximal or 
endurance field walking test, further assessment with ambulatory oxygen is 
recommended. Assuming these patients show clinical benefit with oxygen, 
ambulatory oxygen prescription is advised (5;6). However, current guidelines do not 
specify whether endurance tests or maximal tests should be used in the evaluation of 
exercise induced desaturation nor do they stipulate walking rather than cycle 
ergometry. Field walking tests have been found to be more sensitive to blood oxygen 
changes than cycle-ergometry suggesting walking tests are appropriate for the 
assessment of ambulatory oxygen (8). However, two measures often used 
interchangeably, the Incremental Shuttle (ISWT) and the Six Minute (6MWT) Walking 
Tests induce different physiological responses. The ISWT demonstrates a strong 
correlation with maximal oxygen consumption (VO2 max) (9;10). Whilst data suggests 
that 6MWT demonstrates maximal sustainable activity levels (11) and a review of the 
two tests purports the 6MWT to be a better assessment of daily function in COPD 
(12). The 6MWT is self paced as opposed to the externally paced measure that 
stresses the patient to a symptom-limited maximum (13). Other comparative studies 
show that 6MWT and ISWT provoke different physiological responses in COPD 
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patients. The ISWT demonstrates a linear increment in heart rate, similar to that of 
incremental cycle-ergometry, in contrast 6MWT shows a plateau effect (8). However, 
the two walking tests result in similar mean end values for oxygen saturation, 
dyspnoea score and heart rate (14;15). Whilst this would suggest a similar 
performance in both tests, there is no clear evidence that the tests can be used 
interchangeably in assessment of ambulatory oxygen. Physiotherapists, positioned 
as they are in pulmonary rehabilitation, are at the forefront of exercise assessment in 
COPD. Thus it is imperative that the implications of the effects of different exercise 
tests on oxygen desaturation are explored. 
 
The purpose of this study therefore is to compare change in oxygen saturation, 
dyspnoea score and heart rate in COPD between ISWT and 6MWT.  Additionally, we 
will identify numbers of COPD patients meeting the criteria for ambulatory oxygen 
assessment with each test.   
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MATERIAL AND METHODS: 
 
Patients 
Patients were recruited from the chest clinic at St. George’s Hospital, London. Fifty 
patients were included in the study with mild-to-severe COPD and had had no 
exacerbation in previous 6 weeks as defined by the National Institute for Health and 
Clinical Excellence (NICE) guidelines  (16). All patients had limited exercise tolerance 
due to dyspnoea and were referred to the study by their general practitioner, hospital 
consultant, respiratory nurse or physiotherapist.  All provided written informed 
consent. Exclusion criteria consisted of recent exacerbation, unstable angina, 
significant co-morbidities such as stroke or carcinoma, psychiatric disorders, 
intermittent claudication or other mobility limiting conditions. Full ethical consent was 
obtained from Wandsworth Local Research Ethics Committee and the study was 
conducted according to the Helsinki good practice declaration. 
 
Assessments 
At the initial assessment session demographic data (age, gender); height (cm) and 
weight (kg) were recorded. Body Mass Index (BMI) was calculated from weight (kg) 
divided by square of the height (m) (kg/m2).  Spirometry; Forced Expiratory Volume in 
one second (FEV1) and Forced Expiratory Capacity and (FVC), were measured using 
Vmax 29c; SensorMedics (Yorba Linda, CA, USA) Cardiopulmonary Exercise Testing 
Instrument and in accordance with British Thoracic Society Guidelines. All patients 
performed both Shuttle Walk and 6 Minute Walk Tests whilst breathing air. The 
walking tests were performed on separate days over a period of one week in random 
order.  
 
 
Incremental Shuttle Walking Test, an incremental, externally paced exercise 
capacity test was conducted according to standardised procedure (17). Patients were 
asked to walk around two cones placed at either end of a 9 meter course. The 
walking speed was indicated by signals played from the cassette and increased 
every minute. The test was terminated when the patient was either too breathless to 
continue or could no longer keep up with required speed. The standardised tape 
instruction was played to the patient prior the test. Patients performed two ISWT with 
a break of 30 minutes between them. The results of the best test were recorded as 
actual values. 
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Six Minute Walking Test, a submaximal, self-paced exercise capacity test was 
conducted according to American Thoracic Society (ATS) guidelines (12). Patients 
were required to walk for six minutes at their own pace along a 30 meter corridor. 
The patient was permitted to slow down, stop or rest if necessary. Standardised 
instruction was given prior to testing. Two repeatable tests were taken (repeatability 
was defined as a difference between walks of less than 50 m), we have used this 
conservative estimate based on the mean minimal clinically important difference for 
6MWT (18). Results of the best test were recorded as actual values and patients 
rested for 30 minutes between tests.  
 
Measures were taken by the same investigator before and after each walking test to 
examine physiological responses to the exercise. Breathlessness was assessed with 
Borg CR 10 Scale (Dyspnoea assessment)(19). Percutaneous arterial oxygen 
saturation (SpO2) and heart rate were measured using a pulse oximeter (Pulsox-3i- 
Konika Minolta, Osaka, Japan) applied to the finger.    
 
Statistical Analysis: 
All data are expressed as mean and standard deviation (SD). Change (Δ) in 
variables was calculated by end value minus resting value. All change data were 
normally distributed, except change in oxygen saturation after 6MWT and ISWT. 
Data for these variables were log transformed to achieve a normal curve. The Bland 
and Altman method for assessing agreement between two clinical measurements 
was used for comparison of changes in oxygen saturation between the walking tests 
and limits of agreement were calculated as described (20). The Spearman’s 
correlation was used to assess relationship between changes in SpO2 with both 
tests.  
 
Patients who showed desaturation of 4% or more to below 90% were defined as 
appropriate for stage 2 assessment (Figure 1 shows the stages of ambulatory 
therapy as outlined by BTS guidance, only stage 1 was performed in this study). 
Using Wilcoxon Signed Ranks Test, the number of patients qualifying for stage 2 
ambulatory oxygen assessment was compared according to the walk test. 
Significance was accepted as p <0.05. Data were analysed using SPSS 12.0 for 
Windows. 
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Figure 1.  Assessment for ambulatory oxygen therapy for patients demonstrating exercise desaturation (not prescribed Long Term Oxygen 
Therapy) adapted from the BTS guidelines 2006 for England and Wales 
 
Stage 1. Assessment on air to screen patients with 
possible exercise de-saturation 
Walk test on air 
SpO2 Pre test 
 
SpO2 Post 
test 
 SpO2 post test < 90% & 
 fall in SpO2 ≥ 4% 
NO  
No further ambulatory oxygen assessment indicated 
YES 
Further ambulatory oxygen assessment indicated (Stage 2) 
Stage 2. Assessment with supplementary oxygen to 
correct hypoxemia and determine flow rate 
AMBULATORY OXYGEN THERAPY ASSESSMENT 
 
SpO2 Pre test 
 
SpO2 Post 
test 
 
Walk test on oxygen (min possible flow) 
SpO2 post test ≥ 90%  
& patient shows clinical benefit of reduced breathlessness 
or increased exercise tolerance  
 
YES 
Ambulatory oxygen prescription 
NO 
Ambulatory oxygen should not be prescribed / titrated to a higher oxygen concentration 
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RESULTS 
 
Patient Details 
 
Fifty patients entered the study of whom thirty-one were male. Six Minute Walk 
Distance data was unavailable for one subject. All had a diagnosis of COPD, mean 
FEV1 (SD) 1.24(0.62) l. Baseline characteristics are shown in table 1. 
 
Physiological response measures 
 
There was a significant difference in the walking distance between both tests mean 
(SD) ISWT 216 (149) m and 6MWT 365 (157) m (p< 0.001). Prior to the walking tests 
mean baseline SpO2 levels were similar; 6MWT 94.5 (2.4) % compared with SpO2 
levels prior to ISWT 95.2 (2.0) %. Table 2 shows mean end values and changes in 
oxygen saturation, heart rate and dyspnoea score between the two tests.  
 
Figure 2 represents the Bland and Altman plot showing the difference in the change 
in oxygen saturation between the two tests and the mean change between paired 
scores. The mean difference between the tests was 1.74 % with 95% confidence 
interval 0.34 to 3.14 %. The limits of agreement for difference in change in SpO2 (%) 
between the two tests were wide (-8.1 to 11.6) and clinically relevant. These data tell 
us that the fall in SpO2 after 6MWT may be as much as 8.1% greater than fall in SpO2 
after ISWT, or that the fall in SpO2 post ISWT may be as much as 11.6 % greater 
than fall after 6MWT. As expected, change in SpO2 after ISWT was correlated with 
change in SpO2 after 6MWT, however this correlation was weak and showed a large 
degree of scatter (r=0.49, p<0.001) (Figure 3). 
  
The number of patients with oxygen saturation below 90% after either walk was 
similar (p = 0.26). Overall 19 (38%) of our patients met the criteria for ambulatory 
oxygen assessment (6) using either test but the tests agreed in only 10 of these 
patients.    
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Table 1. Baseline characteristics.  
*BMI = Body Mass Index (weight kg /height m 2) 
 N Mean  SD 
Age (years) 50 67.0  10.5 
BMI* (kg/m2) 50 26.7  5.7 
FEV1 (l) 49 1.24  0.62 
FEV1 % predicted 49 48.6  23.4 
FVC (l)  49 2.2  0.76 
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Table 2. Mean (SD) end values and changes in oxygen saturation, heart rate and dyspnoea for both walking tests.    
6MWT = Six Minute Walk Test, ISWT = Incremental Shuttle Walking Test 
 
  
N 
 
 
6MWT 
Mean (SD) 
 
ISWT 
Mean (SD) 
 
Mean difference 
(SD) 
Arterial oxygen saturation 
post walk (%SpO2) 
50 91.7 (6.1) 90.6 (6.9) 1.0 (4.5) 
Change in arterial oxygen 
saturation (∆%SpO2) 
50 -2.8 (5.3) -4.6 (6.2) 1.7 (5.0) 
End heart rate (bpm) 49 97.4 (20.0) 103.0 (16.2) -5.6 (22.2) 
Change in heart rate (∆bpm) 49 11.4(14.5) 19.9(16.3) -8.5(2.8) 
Dyspnoea score (Borg) 49 3.9 (1.5) 4.1 (1.6) -0.2 (1.1) 
Change in CR10 Borg (∆ 
Borg) 
49 3.2(1.3) 3.1(1.4) 0.6(1.1) 
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Figure 2. Bland and Altman plot for change in oxygen saturation (%SpO2) 
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Figure 3. Relationship between change in arterial oxygen saturation (SpO2) with 6MWT and ISWT (r=0.49). The reference lines represent fall 
in oxygen saturation by 4%; 6MWT- Six Minute Walk Test, ISWT- Incremental Shuttle Walking Test 
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DISCUSSION 
 
This study provides comparative data concerning the use of the Incremental Shuttle 
and Six Minute Walk Tests and relative exercise induced desaturation. These data 
confirm previous work showing different physiological responses according to the two 
tests but that heart rate and arterial oxygen saturation end point levels do not differ 
between tests.  However, analysis of the change in variables show that the ISWT had 
a greater impact on the cardio-respiratory response to exercise and induced greater 
exercise hypoxaemia compared with the 6MWT. The mean difference in oxygen 
desaturation between the tests was small. However, further analysis reveals that the 
limits of agreement between levels of desaturation with these two tests are too wide 
to enable us to confidently use the tests interchangeably for clinical purpose. These 
findings show that, when change in exercise desaturation is a critical factor for 
treatment prescription, the 6MWT or the ISWT only must be used.  The number of 
patients meeting criteria for further assessment for ambulatory oxygen differs 
according to the walking test used.  
 
Vagaggini and colleagues (15), showed no difference between these walking tests in 
terms of oxygen saturation or heart rate in COPD patients recovering from an acute 
exacerbation. The patients in our study, however, were clinically stable, which could 
explain the different physiological responses between studies. Assessment for 
ambulatory and long term oxygen therapy should only be performed in stable COPD 
patients suggesting that our data is more robust when considering this purpose.  
However, in our study we performed the walking tests on separate days and 
therefore variations in patient condition may have influenced the results. In clinical 
practice tests are likely to be performed on the same day which may provide more 
robust data.  
 
The prescription of ambulatory oxygen per se remains controversial. One recent 
review of long term evaluation of ambulatory oxygen suggests there is insufficient 
evidence to demonstrate efficacy of the addition of ambulatory oxygen to daily life 
compared with placebo (21). Although, a review of the short term benefit, based on 
response from acute exercise tests, demonstrates significant increases in exercise 
tolerance and breathlessness (5). However, assuming, short term benefit in some 
patients translates into longer term efficacy (and studies are required to show this) 
then accurate assessment of ambulatory oxygen therapy becomes paramount.  
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Evaluation of appropriate assessment for ambulatory oxygen requires 
standardisation. However, it is not clear which test or which measure is a better 
indicator of a patient’s requirement for ambulatory oxygen therapy.  
 
In a recent study by Morante and colleagues (22) ambulatory oxygen therapy was 
assessed according to Spanish guidelines. This method considered the mean 
oxygen saturation value throughout the test rather than the end point. Using this 
method the 6MWT was effective in the detection of desaturation during daily activities 
and for establishing the correct oxygen level to overcome desaturation. However, 
they did not compare 6MWT with any another test. Unfortunately, in our study we did 
not assess activities of daily living and therefore cannot make comparisons of the 
relative value of ISWT or 6MWT in this respect. Furthermore we have only 
considered the assessment for ambulatory oxygen at stage 1 and cannot determine 
from our data which test would most useful for titration of oxygen concentration. We 
suggest that future studies considering comparison of walking tests in the evaluation 
of oxygen desaturation should apply the methods described by Morante. This is of 
particular relevance when considering that patients may stop walking during the 
6MWT which in turn could affect end SpO2. 
 
Assessment tests should be linked to appropriate provision of treatment in 
concordance with patient goals. The concept of ambulatory oxygen therapy is such 
that oxygen is administered during exercise or daily activity and, as such the amount 
of activity an individual performs will influence choice of delivery. In COPD patients a 
fall in oxygen saturation is reported mainly during walking, washing and eating (1;23).  
The purpose of provision of ambulatory oxygen requires consideration when 
choosing the assessment method. If assessment is performed to evaluate oxygen 
requirements during maximal exercise a robust maximal test such as ISWT may be 
most appropriate. However, ambulatory oxygen is associated with the inconvenience 
of using a supplementary device and oxygen itself can be hazardous (24) and 
assessment is required that minimises over prescription of oxygen but maximises 
potential use.  Clinicians should be aware that choice of walking test will influence the 
numbers of patients deemed to require oxygen (although not statistically significant in 
this study) and as demand increases the choice of assessment test will have greater 
impact on the numbers of patients receiving oxygen. As yet, there is no evidence that 
long-term benefit is determined from any short-term assessment. In conclusion, our 
data shows wide variation between differences in exercise desaturation after ISWT 
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compared with 6MWT supporting the premise that these tests should not be used 
interchangeably.    
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